You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SGN Benda

Showing 1 - 25 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma Trial in New York, Vancouver, Toronto (Brentuximab Vedotin, Bendamustine,

Completed
  • Hodgkin Lymphoma
  • Anaplastic Large Cell Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • New York, New York
  • +2 more
Jul 15, 2020

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Colorectal Tumors, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial (SGN-EGFRd2)

Not yet recruiting
  • Colorectal Neoplasms
  • +3 more
  • (no location specified)
Aug 1, 2023

Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

Not yet recruiting
  • Colorectal Neoplasms
  • +5 more
  • (no location specified)
Nov 9, 2023

Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Tumors, Ovarian Tumors Trial in Worldwide (SGN-STNV)

Recruiting
  • Carcinoma, Non-Small Cell Lung
  • +11 more
  • Los Angeles, California
  • +16 more
Aug 15, 2022

Cutaneous Melanoma, NSCLC, Colorectal Tumors Trial in Denver (SGN-BB228)

Recruiting
  • Cutaneous Melanoma
  • +4 more
  • Denver, Colorado
    Sarah Cannon Research Institute at HealthONE - Denver
Jan 17, 2023

Ovarian Tumors, Endometrial Tumors, NSCLC Trial in United Kingdom, United States (SGN-ALPV)

Recruiting
  • Ovarian Neoplasms
  • +5 more
  • Fresno, California
  • +10 more
Jan 20, 2023

Cutaneous Melanoma, Pleural Mesothelioma, HER2 Negative Breast Tumors Trial in Worldwide (SGN-CD228A)

Active, not recruiting
  • Cutaneous Melanoma
  • +5 more
  • Birmingham, Alabama
  • +13 more
Jan 23, 2023

NSCLC, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma Trial in San Antonio, West Valley City,

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • San Antonio, Texas
  • +2 more
Aug 15, 2022

Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in United States (SGN-B7H4V)

Recruiting
  • Ovarian Neoplasms
  • +9 more
  • Aurora, Colorado
  • +6 more
Aug 15, 2022

NSCLC Trial (SGN-B6A, docetaxel)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 21, 2023

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

DLBCL, Lymphoma Follicular Trial in Australia, Italy, United States (Atezolizumab, Bendamustine, Cyclophosphamide)

Completed
Has Results
  • Diffuse Large B-Cell Lymphoma, Lymphoma Follicular
  • Aurora, Colorado
  • +20 more
Apr 26, 2021

Triple Negative Breast Tumors Trial in Worldwide (ladiratuzumab vedotin, Pembrolizumab)

Recruiting
  • Triple Negative Breast Neoplasms
  • Birmingham, Alabama
  • +49 more
Jan 4, 2023

Hodgkin Lymphoma Trial in New York (Mocetinostat Plus Brentuximab Vedotin)

Completed
Has Results
  • Hodgkin Lymphoma
  • Mocetinostat Plus Brentuximab Vedotin
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 10, 2022

Disease, Hodgkin Trial in Worldwide (brentuximab vedotin, )

Completed
Has Results
  • Disease, Hodgkin
  • brentuximab vedotin
  • placebo
  • Duarte, California
  • +86 more
Apr 22, 2021

HIV Infection, HIV-associated Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma Trial in France (brentuximab vedotin,

Active, not recruiting
  • HIV Infection
  • +3 more
  • brentuximab vedotin
  • +3 more
  • Clamart, France
  • +5 more
Aug 11, 2022

Soft Tissue Sarcoma, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (SGN-CD47M)

Terminated
  • Soft Tissue Sarcoma
  • +8 more
  • Cleveland, Ohio
  • +4 more
Sep 15, 2020

Multiple Myeloma Trial in United States (SGN-CD48A)

Terminated
  • Multiple Myeloma
  • San Francisco, California
  • +5 more
Sep 16, 2019

Primary Cutaneous Anaplastic Large Cell Lymphoma, Mycosis Fungoides, Cutaneous T-Cell Lymphoma Trial in Worldwide (Brentuximab

Completed
Has Results
  • Primary Cutaneous Anaplastic Large Cell Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • +2 more
  • Los Angeles, California
  • +40 more
Dec 16, 2020

Multiple Myeloma Trial in United States (SGN-CD352A)

Terminated
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +10 more
Aug 8, 2019

NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Birmingham, Alabama
  • +10 more
Jul 17, 2019

Myelodysplastic Syndrome Trial in United States (vadastuximab talirine, Azacitidine, Placebo (for 33A))

Terminated
Has Results
  • Myelodysplastic Syndrome
  • vadastuximab talirine
  • +2 more
  • Gilbert, Arizona
  • +33 more
Jan 23, 2019

Acute Myeloid Leukemia Trial in Worldwide (33A, , azacitidine)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Little Rock, Arkansas
  • +127 more
Nov 21, 2018

Lymphoma, B-cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Grade 3b Trial in United States (denintuzumab

Terminated
Has Results
  • Lymphoma, B-cell
  • +3 more
  • denintuzumab mafodotin
  • +4 more
  • Little Rock, Arkansas
  • +28 more
Apr 19, 2019